Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience.

International journal of molecular sciences - 1 Mar 2022

Bonifacio Maria Addolorata, Genchi Chiara, Lagioia Antonella, Talamo Vincenza, Volpe Anna, Mariggiò Maria Addolorata

Abstract excerpt

Drug-resistance monitoring is one of the hardest challenges in HIV management. Next-generation sequencing (NGS) technologies speed up the detection of drug resistance, allowing the adjustment of antiretroviral therapy and enhancing the quality of life of people living with HIV. Recently, the NGS Sentosa® SQ HIV Genotyping Assay (Vela Diagnostics) received approval for in vitro diagnostics use. This work is the...

Topics

Anti-HIV Agents
Drug Resistance, Viral
Genotype
HIV Infections
HIV-1
High-Throughput Nucleotide Sequencing
Humans
Mutation
Quality of Life
RNA, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Reproducibility of Results

Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 35269868
DOI: 10.3390/ijms23052727
PMCID: PMC8911269

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience.PMID 35269868Read ↗

Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.Semantic proximity Read ↗

Assessment of intra-sample variability in HIV-1 DNA drug resistance genotyping.Semantic proximity Read ↗

HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.Semantic proximity Read ↗

Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy.Semantic proximity Read ↗

Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance.Semantic proximity Read ↗

Next Generation Sequencing Based In-house HIV Genotyping Method: Validation ReportSemantic proximity Read ↗

Next generation sequencing based in-house HIV genotyping method: validation report.Semantic proximity Read ↗

Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.Semantic proximity Read ↗

Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance TestingSemantic proximity Read ↗

Deep sequencing for HIV-1 clinical management.Semantic proximity Read ↗

Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samples.Semantic proximity Read ↗

Technologies for HIV-1 drug resistance testing: inventory and needs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.